We then used our CRISPR-Cas-based enrichment protocol to target the FMR1 locus from cultured cells of sample NA06896, derived from an unaffected female heterozygous carrier of FXS, and measured repeat lengths using this opening assay. This evidence concerns the gene FMR1 and fragile X syndrome.